Could Low Dose Naltrexone help millions worldwide live a better quality of life? In 1985, Bernard Bihari MD, a physician with clinical practice in New York, discovered the effects of Naltrexone in a dose ranging from 1-4.5 mg. Clinical trials around the world have shown low doses of Naltrexone to be a promising treatment for many immune related diseases, such as Multiple Sclerosis and Crohn’s disease. Low Dose Naltrexone has also been tested for treatments in other idiopathic disease states such as fibromyalgia. For years, doctors had been strenuously trying to find the mechanism for the therapeutic effect of Low Dose Naltrexone.
Patients at Johnson Compounding are prescribed Low Dose Naltrexone for Multiple Sclerosis, Lyme Disease, Fibromyalgia, Crohn’s Disease, Cancer and many other very serious health conditions. Low Dose Naltrexone is cost effective and comes in capsule or cream form.
Since 1985 there has been much more information available regarding LDN. However, there is still a great need for more education – for patients and their providers. Nowadays, there is a good numbers of resources: conferences, websites, and blogs to try and get the word out about LDN. Could Low Dose Naltrexone be the next wonder drug? Here are a few resources to learn more about LDN: LDN Research Trust, LDN Info, LDNers.
For more information about Low Dose Naltrexone, please feel free to reach out to our pharmacists who can refer you to a doctor who is familiar with the different LDN protocols.
What is transfer factor? First discovered by immunologist H. Sherwood Lawrence in 1949, transfer factors are immune messenger molecules comprised of amino acids. In mammals